When institutional investors bought into a $1.8 billion leveraged loan syndication for Millennium Laboratories in 2014, they had no idea what they were getting into.
When institutional investors bought into a $1.8 billion leveraged loan syndication for Millennium Laboratories in 2014, they had no idea what they were getting into.